Melanoma Coverage from Every Angle

Recent News

Cryopreserved Lifileucel in Advanced Refractory Metastatic Melanoma
Quality Care 2019: Effect of Interdisciplinary Shared Medical Appointments on Melanoma Survivors
Can Targeting Brain Pathways Inhibit Brain Metastasis in Patients With Melanoma?
Triple-Drug Therapy Under Study in BRAF-Mutant Melanoma
Does Combination Immunotherapy Improve Survival in Metastatic Uveal Melanoma?
Epacadostat With Pembrolizumab in Advanced Melanoma
Genetics + Environment: Evidence of Synergy in Increasing Skin Cancer Risk
Bempegaldesleukin With Nivolumab Granted Breakthrough Therapy Designation in Melanoma
Assessing Anti–PD-1 Therapy Efficacy After Complete Response in Melanoma
COLUMBUS Trial: Updated Outcomes With BRAF/MEK Inhibitors in Advanced Melanoma
Novel Immunotherapy Combination Active in Metastatic Melanoma
FDA Accepts sBLAs for 6-Week Dosing Schedule of Pembrolizumab for Melanoma
WCD 2019: Can Reflectance Confocal Microscopy Prevent Unnecessary Skin Lesion Excision?
Predicting Response to Immunotherapy in Metastatic Melanoma
ASCO 2019: Predicting Treatment Outcomes in Melanoma With Circulating Tumor DNA Kinetics
ASCO 2019: Survival Update on Dabrafenib Plus Trametinib in BRAF V600–Mutant Melanoma
Can Novel Imaging Technique Diagnose and Treat Skin Cancer Without Cutting Skin?
ASCO 2019: Continued Benefit Reported With Adjvuant Ipilimumab in Resected Melanoma
ASCO 2019: Neoadjuvant Therapy in Melanoma: Pathologic Response and Relapse
ASCO 2019: Nivolumab Plus Ipilimumab for Symptomatic Melanoma Brain Metastases
ASCO 2019: Whole-Brain Radiation vs. Observation for Melanoma Brain Metastases
EORTC Updates Sentinel Lymph Node Biopsy Protocol in Melanoma
Is BRAF V600E Mutation of Prognostic Value in Nonmetastatic Melanoma?
Sentinel Lymph Node Biopsy After Wide Local Excision for Melanoma of the Head and Neck
Pediatric Case of Spitzoid Melanoma: Focus on MAP3K8 Signaling Cascade
Are Girls at Higher Risk Than Boys of Developing Melanoma?
Role for Oxoglutarate Carrier in Formation of Melanoma
Novel Approach to Predicting Adverse and Beneficial Effects of Immunologic Interventions
AACR 2019: Entinostat Plus Pembrolizumab for Melanoma After Immunotherapy
FDA Fast Track Designation: Tebentafusp in Metastatic Uveal Melanoma
Skin Cancer 2019: Can Microneedle Technology Improve Skin Cancer Treatment?
AACR 2019: Can B Cells Predict Response to Immunotherapy in Melanoma?
AACR 2019: Impact of Probiotics and Fiber on Gut Microbiome and Immunotherapy Response
Society of Behavioral Medicine Conference 2019: Web-Based Intervention for Melanoma Prevention
FDA Proposes Updated Requirements for Sunscreen Products

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.